Stair Climbing Exercise Versus Traditional Resistance Exercise
NCT05263115, Not applicable, Completed, KU Leuven
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Stair Climbing Exercise Versus Traditional Resistance Exercise | ClinicalTrials.gov |
| NCT number | NCT05263115 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 46 participants, actual | ClinicalTrials.gov |
| Lead sponsor | KU Leuven | ClinicalTrials.gov |
| Conditions | Exercise Training | ClinicalTrials.gov |
| Interventions | Resistance Exercise intervention, Functional stair climbing and stepping-based exercise intervention | ClinicalTrials.gov |
| First posted | 2022-03-02 | ClinicalTrials.gov |
| Last updated | 2023-01-23 | ClinicalTrials.gov |
Registered outcomes 11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | F-V profile | Change from baseline in F-v profile at 12 weeks | Force-velocity profiling is carried out unilaterally (dominant leg) on the pneumatic leg press device (Leg Press CC, HUR, Kokkola, Finland). The test protocol consists of a maximal isometric test (knee joint angle = 85°, hip angle = 55°; 3 attempts of 3s), followed by explosive concentric leg extensions at gradually increasing loads (unloaded, 15%, 30%, 45%, 60%, 75% of the maximal isometric force, 2-3 attempts per load, and additional single repetitions until one-repetition maximum is reached). Mean velocity of the best trial per load is used to estimate the individual F-v relationship through a linear equation. This F-v relationship will be used to examine the exercise-induced adaptations. F0 (maximal force), v0 (maximal velocity), a (the equation's slope), Pmax (maximal power) and the corresponding v and F at Pmax are used for the analyses. | ClinicalTrials.gov |
| Secondary | Gait speed | Change from baseline in gait speed at 12 weeks | The average speed to walk 10m as fast as possible (in m/s) | ClinicalTrials.gov |
| Secondary | 5-repetition sit-to-stand time | Change from baseline in sit-to-stand performance at 12 weeks | The time (s) needed to perform 5 sit-to-stand transitions. | ClinicalTrials.gov |
| Secondary | 5-repetition sit-to-stand power | Change from baseline in sit-to-stand performance at 12 weeks | The power (watt) needed to perform 5 sit-to-stand transitions. | ClinicalTrials.gov |
| Secondary | Stair ascent time | Change from baseline in stair climbing performance at 12 weeks. | The time (s) needed to ascend a flight of stairs. | ClinicalTrials.gov |
| Secondary | Stair ascent power | Change from baseline in stair climbing performance at 12 weeks. | The power (watt) needed to ascend a flight of stairs. | ClinicalTrials.gov |
| Secondary | Countermovement jump height | Change from baseline in countermovement jump height at 12 weeks. | Jump height (cm) in a countermovement jump | ClinicalTrials.gov |
| Secondary | MoCA test score | Change from baseline in Montrial Cognitive Assessment test score at 12 weeks. | Total score (min 0, max 30, higher scores indicate better performance) on the Montreal Cognitive Assessment test | ClinicalTrials.gov |
| Secondary | Digit Span Test score | Change from baseline in Digit Span Test score at 12 weeks. | Total score (min 0, max 30, higher scores indicate better performance) on the Digit Span Test | ClinicalTrials.gov |
| Secondary | Trail Making Test Time | Change from baseline in Trail Making Test at 12 weeks. | Total duration (s) needed to complete the Trail Making Test. | ClinicalTrials.gov |
| Secondary | Stroop Test number of words | Change from baseline in Stroop Test at 12 weeks. | Total number of words red in 45s in the stroop test. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|---|---|
| 39590559 | DERIVED | PubMed |
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
| Trail Making Test A | Secondary outcome | ConductCognition |
| Trail Making Test B | Secondary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)